The Global Monkeypox (Mpox) Outbreak: A Comprehensive Review
暂无分享,去创建一个
S Kumar | B. Padhi | R. Sah | Shriyansh Srivastava | A. Mohanty | Shagun Jain | Neeraj Thapa | K. Bhusal | Prabhat Poudel | Z. H. Al-qaim | J. J. Barboza
[1] C. Bréchot,et al. Choosing the Right Path toward Polio Eradication. , 2023, The New England journal of medicine.
[2] Moslem Ghaseminia. Preventing monkeypox outbreaks: Focus on diagnosis, care, treatment, and vaccination , 2023, Journal of Clinical and Translational Science.
[3] M. Lounis,et al. Monkeypox (MPOX)-Related Knowledge and Vaccination Hesitancy in Non-Endemic Countries: Concise Literature Review , 2023, Vaccines.
[4] Z. Liu,et al. The land-scape of immune response to monkeypox virus , 2022, EBioMedicine.
[5] Jonathan Bryant-Genevier,et al. Epidemiologic Features of the Monkeypox Outbreak and the Public Health Response — United States, May 17–October 6, 2022 , 2022, MMWR. Morbidity and mortality weekly report.
[6] H. Lopez-Gatell,et al. Epidemiological and clinical characteristics of patients with human monkeypox infection in Mexico: a nationwide observational study , 2022, Lancet Regional Health. Americas.
[7] Z. Liu,et al. The evolving epidemiology of monkeypox virus , 2022, Cytokine & growth factor reviews.
[8] Mana Rao,et al. A Review of Monkeypox: The New Global Health Emergency , 2022, Venereology.
[9] K. Bibby,et al. Model-Based Theoretical Evaluation of the Feasibility of Using Wastewater-Based Epidemiology to Monitor Monkeypox , 2022, Environmental Science & Technology Letters.
[10] E. Puca,et al. Diagnosis of monkeypox virus – An overview , 2022, Travel medicine and infectious disease.
[11] A. Rodríguez-Morales,et al. Human monkeypox disease (MPX). , 2022, Le infezioni in medicina.
[12] S. Laivacuma,et al. The virology of human monkeypox virus (hMPXV): A brief overview , 2022, Virus research.
[13] J. Brooks,et al. Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection — United States, August 2022 , 2022, MMWR. Morbidity and mortality weekly report.
[14] E. Durante-Mangoni,et al. Monkeypox infection: An update for the practicing physician , 2022, European journal of internal medicine.
[15] E. Nicastri,et al. Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding , 2022, The Lancet. Infectious diseases.
[16] G. Srivastava,et al. Human monkeypox disease , 2022, Clinics in Dermatology.
[17] A. Rodríguez-Morales,et al. Monkeypox and Its Possible Sexual Transmission: Where Are We Now with Its Evidence? , 2022, Pathogens.
[18] D. Chilton,et al. Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series , 2022, BMJ.
[19] A. Antinori,et al. Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. , 2022, The New England journal of medicine.
[20] Gabriel Alugba,et al. Monkeypox: A Review of Clinical Features, Diagnosis, and Treatment , 2022, Cureus.
[21] J. Kaler,et al. Monkeypox: A Comprehensive Review of Transmission, Pathogenesis, and Manifestation , 2022, Cureus.
[22] A. Rodríguez-Morales,et al. Monkeypox outbreaks during COVID-19 pandemic: are we looking at an independent phenomenon or an overlapping pandemic? , 2022, Annals of clinical microbiology and antimicrobials.
[23] Rita Patrocínio-Jesus,et al. Monkeypox Genital Lesions. , 2022, The New England journal of medicine.
[24] Allen Cheng,et al. Monkeypox infection presenting as genital rash, Australia, May 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[25] S. Riley,et al. Community transmission of monkeypox in the United Kingdom, April to May 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[26] T. Velavan,et al. Monkeypox 2022 outbreak: An update , 2022, Tropical medicine & international health : TM & IH.
[27] Max Kozlov. Monkeypox outbreaks: 4 key questions researchers have , 2022, Nature.
[28] B. Bell,et al. Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 , 2022, MMWR. Morbidity and mortality weekly report.
[29] Zhilong Yang,et al. Monkeypox: A potential global threat? , 2022, Journal of medical virology.
[30] T. Inglesby,et al. A Novel International Monkeypox Outbreak , 2022, Annals of Internal Medicine.
[31] Max Kozlov. Monkeypox goes global: why scientists are on alert , 2022, Nature.
[32] B. Medhi,et al. Monkeypox infection: A quick glance , 2022, Indian journal of pharmacology.
[33] U. Awan,et al. Monkeypox: A new threat at our doorstep! , 2022, The Journal of infection.
[34] Jennifer L. Small,et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK , 2022, The Lancet. Infectious diseases.
[35] H. Adler,et al. Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom, May 2021 , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[36] Y. Nakazawa,et al. Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model , 2021, mSphere.
[37] U. Moens,et al. Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution , 2020, Viruses.
[38] Anna M. Mandra,et al. Exportation of Monkeypox Virus From the African Continent , 2020, The Journal of infectious diseases.
[39] R. Breban,et al. Modelling human-to-human transmission of monkeypox , 2020, Bulletin of the World Health Organization.
[40] S. Tabrez,et al. Novel COVID-19: A Comprehensive Review of Transmission, Manifestation, and Pathogenesis , 2020, Cureus.
[41] J. Dunning,et al. Human-to-Human Transmission of Monkeypox Virus, United Kingdom, October 2018 , 2020, Emerging infectious diseases.
[42] E. Overton,et al. A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS. , 2020, Vaccine.
[43] G. Krause,et al. Use of Surveillance Outbreak Response Management and Analysis System for Human Monkeypox Outbreak, Nigeria, 2017–2019 , 2020, Emerging infectious diseases.
[44] Joachim Hornung,et al. Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox. , 2019, The New England journal of medicine.
[45] R. Lin,et al. A case of imported Monkeypox in Singapore , 2019, The Lancet Infectious Diseases.
[46] Anna M. Mandra,et al. Outbreak of human monkeypox in Nigeria in 2017–18: a clinical and epidemiological report , 2019, The Lancet. Infectious diseases.
[47] H. Achdout,et al. Diagnosis of Imported Monkeypox, Israel, 2018 , 2019, Emerging infectious diseases.
[48] Y. Nakazawa,et al. Epidemiologic and Ecologic Investigations of Monkeypox, Likouala Department, Republic of the Congo, 2017 , 2019, Emerging infectious diseases.
[49] B. Monroe,et al. Vaccinating against monkeypox in the Democratic Republic of the Congo , 2018, Antiviral research.
[50] Jennifer Wilburn,et al. Two cases of monkeypox imported to the United Kingdom, September 2018 , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[51] Ousmane Faye,et al. Reemergence of Human Monkeypox in Nigeria, 2017 , 2018, Emerging infectious diseases.
[52] Y. Nakazawa,et al. Emergence of Monkeypox — West and Central Africa, 1970–2017 , 2018, MMWR. Morbidity and mortality weekly report.
[53] B. Drumond,et al. Poxvirus Host Range Genes and Virus–Host Spectrum: A Critical Review , 2017, Viruses.
[54] Johannes B. Goll,et al. Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial. , 2017, Vaccine.
[55] O. Vapalahti,et al. Emerging diseases—the monkeypox epidemic in the Democratic Republic of the Congo , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[56] L. Harrison,et al. Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses - Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015. , 2016, MMWR. Morbidity and mortality weekly report.
[57] S. Hashizume,et al. Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice. , 2015, Vaccine.
[58] I. Frank,et al. Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial , 2015, Open forum infectious diseases.
[59] Jeffrey R. Kugelman,et al. Genomic Variability of Monkeypox Virus among Humans, Democratic Republic of the Congo , 2014, Emerging infectious diseases.
[60] S. Shchelkunov. An Increasing Danger of Zoonotic Orthopoxvirus Infections , 2013, PLoS pathogens.
[61] Y. Modis. Class II Fusion Proteins , 2013, Advances in experimental medicine and biology.
[62] J. Mercer,et al. Poxvirus host cell entry. , 2012, Current opinion in virology.
[63] I. Damon. Status of human monkeypox: clinical disease, epidemiology and research. , 2011, Vaccine.
[64] P. Jahrling,et al. Systems Kinomics Demonstrates Congo Basin Monkeypox Virus Infection Selectively Modulates Host Cell Signaling Responses as Compared to West African Monkeypox Virus , 2011, Molecular & Cellular Proteomics.
[65] K. Edwards,et al. Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults. , 2011, The Journal of infectious diseases.
[66] A. Legasse,et al. Deletion of the Monkeypox Virus Inhibitor of Complement Enzymes Locus Impacts the Adaptive Immune Response to Monkeypox Virus in a Nonhuman Primate Model of Infection , 2011, Journal of Virology.
[67] Barney S. Graham,et al. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo , 2010, Proceedings of the National Academy of Sciences.
[68] K. Früh,et al. Modulation of the host immune response by cowpox virus , 2010, Microbes and infection.
[69] Niels H. Wulff,et al. A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE. , 2010, Vaccine.
[70] T. Mizutani,et al. Virulence and pathophysiology of the Congo Basin and West African strains of monkeypox virus in non-human primates. , 2009, The Journal of general virology.
[71] S. Isaacs,et al. Monkeypox virus and insights into its immunomodulatory proteins , 2008, Immunological reviews.
[72] C. Pinilla,et al. Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation , 2008, Proceedings of the National Academy of Sciences.
[73] D. Smee. Progress in the Discovery of Compounds Inhibiting Orthopoxviruses in Animal Models , 2008, Antiviral chemistry & chemotherapy.
[74] Lihan K. Yan,et al. Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge. , 2007, Vaccine.
[75] J. Melski,et al. Monkeypox: An epidemiologic and clinical comparison of African and US disease , 2006, Journal of the American Academy of Dermatology.
[76] Yu Li,et al. Genome Sequence Diversity and Clues to the Evolution of Variola (Smallpox) Virus , 2006, Science.
[77] S. Bavari,et al. Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[78] P. Jahrling,et al. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin , 2005, Virology.
[79] T. Kuiken,et al. Modified Vaccinia Virus Ankara Protects Macaques against Respiratory Challenge with Monkeypox Virus , 2005, Journal of Virology.
[80] Scott A. Smith,et al. Immune Response to Poxvirus Infections in Various Animals , 2002, Critical reviews in microbiology.
[81] R. Schauer,et al. A study on the regulation of N-glycoloylneuraminic acid biosynthesis and utilization in rat and mouse liver. , 1990, European journal of biochemistry.
[82] L. Jorde,et al. Smallpox and its eradication in Finland: implications for disease control. , 1989, Population studies.
[83] P E Fine,et al. The transmission potential of monkeypox virus in human populations. , 1988, International journal of epidemiology.
[84] R. A. Okyay. Another Epidemic in the Shadow of Covid 19 Pandemic: A Review of Monkeypox , 2022, Eurasian Journal of Medicine and Oncology.
[85] G. Werneck,et al. What do we need to know about the monkeypox virus infection in humans? , 2022, Cadernos de saude publica.
[86] G. McFadden,et al. Poxviruses and the evolution of host range and virulence. , 2014, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[87] I. Damon,et al. Human monkeypox. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[88] G. McFadden. Poxvirus tropism , 2005, Nature Reviews Microbiology.
[89] Z Jezek,et al. Human monkeypox: secondary attack rates. , 1988, Bulletin of the World Health Organization.